Delivery Order SPE2DB22D3004-SPE2DB24FQE59
Award Date 4/30/24
Potential Completion Date 5/1/24
Potential Value $1.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $5,275.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a pharmaceutical product, with a completion date of October 30, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor and healthcare solutions...
- This federal contract award, valued at $10,460.58, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a completion date of January 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There was no set-aside designation for this award. Amerisourcebergen Drug Corp holds significant Indefinite Delivery Contracts (IDCs)...
- This federal contract award, valued at $15,483.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceuticals, a specialty medication used for medical treatment. The contract has an ultimate completion date of February 12, 2024 and is a firm fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $1,839.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a pharmaceutical product, with a completion date of April 29, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $18,962.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,564,360,952 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has an ultimate completion date of April 23, 2024 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is a large pharmaceutical distributor...
- This federal contract award, valued at $7,722.12, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, and has an ultimate completion date of January 24, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $25,230.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2024 and was awarded on January 30, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition....
- This federal contract award, valued at $16,997.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This contract has a performance period through May 3, 2024 and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $5,171.07, is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 3, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, valued at $11,130.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4564416395 DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a completion date of April 29, 2024. The contract is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...